CARLSMED, INC.

CARLSMED, INC.

CARL - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$408.18M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CARLSMED, INC.CARLSMED, INC.-11--44%7.50.3
$20.00

Target Price by Analysts

33.2% upsideCARLSMED, INC. Target Price DetailsTarget Price

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$408.18 Million
Enterprise Value$383.85 Million
Earnings per Share$-2.12
Beta2.09
Outstanding Shares27,190,765

Return

Return on Equity-43.83%ROE
Return on Assets-31.24%
Return on Invested Capital-29.63%

Valuation & Multiples

P/E Ratio-10.99P/E Ratio
PEG-19.87PEG
Price to Sales7.51Price to Sales
Price to Book Ratio5.01Price to Book Ratio
Enterprise Value to Revenue6.06
Enterprise Value to EBIT-12.24
Enterprise Value to Net Income-11
Total Debt to Enterprise0.06
Debt to Equity0.26Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 27, 2026
EPS Estimate
$-0.40
Consensus analyst estimate
Revenue Estimate
$17.95 M
Consensus analyst estimate

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.42
Consensus analyst estimate
Revenue Estimate
$19.15 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.00%▼ 21.25%
Total Invested$915▼ 100.00%
Investors Holding2▼ 75.00%

About CARLSMED, INC.

100 employees
CEO: Michael John Cordonnier

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. Its product ...

CARLSMED, INC. Insider Information FAQ

Stockcircle tracks 2 top investors with a current 13F position in CARLSMED, INC.. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider sales for CARLSMED, INC. in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.